Please assess the completion status of the following clinical trial:

Trial Title: Daily Chlorhexidine Care at the Exit Site in Peritoneal Dialysis Patients

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: NONE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* patients \> 20 years old who received PD for more than 3 months~Exclusion Criteria:~* a history of psychological illness or condition that interferes with caring of a wound~* recent (within 1 month) exit-site infection, peritonitis, or tunnel infection~* recent treatment with an antibiotic administered by any route in the last month~* or known hypersensitivity to or intolerance of chlorhexidine or mupirocin

- Gender: ALL
- Minimum Age: 20 Years
- Maximum Age: None
- Healthy Volunteers: f

Study Arms:
- Chlorhexidine gluconate (Type: EXPERIMENTAL): PD (peritoneal dialysis) paitents with daily chlorhexidine exit site care
- Control group (Type: NO_INTERVENTION): PD (peritoneal dialysis) patients with usual (Normal saline) exit site care

Based on this trial design, predict the completion outcome and termination type (if applicable).